A part of Watch Medier Medical Writer responsible for Clinical Disclosure Clinical Supply Manager Pharmacokineticist, PK/PD Modelling & Simulation Global Clinical Lead, Clinical Development, Migraine & Pain Senior Safety Manager Director, Drug Safety Operations You need to be a subscriber to read the rest of the article
Perhaps most importantly for weight management, semaglutide acts on appetite-regulating centres in the hypothalamus, reducing hunger signals and food cravings
Merkwirth C, Dargazanli S, Tatsuta T, Geimer S, Lwer B, Wunderlich FT, von Kleist-Retzow JC, Waisman A, Westermann B, Langer T
By mimicking endogenous GLP-1, semaglutide enhances glucose-dependent insulin secretion, suppresses glucagon release, and significantly reduces appetite through central nervous system pathways
As skin cells repair themselves under the antioxidant boost, the surface feels smoother
Targeting iron metabolism and ferroptosis as novel therapeutic approaches in cardiovascular diseases